Attached files

file filename
8-K - FORM 8-K - CRANE CO /DE/d8k.htm
EX-99.1 - EARNINGS PRESS RELEASE - CRANE CO /DE/dex991.htm

Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

 

     Three Months Ended
March 31,
 
     2011     2010  

Net Sales:

    

Aerospace & Electronics

   $ 161,936      $ 133,645   

Engineered Materials

     61,832        53,755   

Merchandising Systems

     94,878        70,171   

Fluid Handling

     264,142        247,789   

Controls

     28,232        24,931   
                

Total Net Sales

   $ 611,020      $ 530,291   
                

Operating Profit (Loss):

    

Aerospace & Electronics

   $ 34,042      $ 24,489   

Engineered Materials

     10,143        8,540   

Merchandising Systems

     4,673        4,969   

Fluid Handling

     35,453        27,989   

Controls

     3,111        126   

Corporate

     (14,562     (12,833
                

Total Operating Profit

     72,860        53,280   

Interest Income

     290        225   

Interest Expense

     (6,622     (6,726

Miscellaneous- Net

     3,625     (21
                

Income Before Income Taxes

     70,153        46,758   

Provision for Income Taxes

     21,775        13,574   
                

Net income before allocations to noncontrolling interests

     48,378        33,184   

Less: Noncontrolling interest in subsidiaries’ losses

     (89     (50
                

Net income attributable to common shareholders

   $ 48,467      $ 33,234   
                

Share Data:

    

Earnings per Diluted Share

   $ 0.81      $ 0.56   
                

Average Diluted Shares Outstanding

     59,552        59,570   

Average Basic Shares Outstanding

     58,330        58,650   

Supplemental Data:

    

Cost of Sales

   $ 397,850      $ 352,271   

Selling, General & Administrative

     140,310        124,740   

Depreciation and Amortization **

     15,774        14,437   

Stock-Based Compensation Expense

     3,503        3,172   

 

* Primarily related to the sale of a building and the divestiture of a small product line in the three months ended March 31, 2011.
** Amount included within cost of sales and selling, general & administrative costs.


CRANE CO.

Condensed Balance Sheets

(in thousands)

 

     March 31,
2011
     December 31,
2010
 

ASSETS

     

Current Assets

     

Cash and Cash Equivalents

   $ 233,162       $ 272,941   

Accounts Receivable, net

     356,257         301,918   

Current Insurance Receivable - Asbestos

     33,000         33,000   

Inventories, net

     347,813         319,077   

Other Current Assets

     75,708         61,725   
                 

Total Current Assets

     1,045,940         988,661   

Property, Plant and Equipment, net

     283,006         280,746   

Long-Term Insurance Receivable - Asbestos

     174,253         180,689   

Other Assets

     424,481         446,316   

Goodwill

     822,516         810,285   
                 

Total Assets

   $ 2,750,196       $ 2,706,697   
                 

LIABILITIES AND EQUITY

     

Current Liabilities

     

Notes Payable and Current Maturities of Long-Term Debt

   $ 916       $ 984   

Accounts Payable

     173,798         157,051   

Current Asbestos Liability

     100,000         100,000   

Accrued Liabilities

     217,685         229,462   

Income Taxes

     13,605         11,057   
                 

Total Current Liabilities

     506,004         498,554   

Long-Term Debt

     398,780         398,736   

Long-Term Deferred Tax Liability

     49,482         48,852   

Long-Term Asbestos Liability

     600,506         619,666   

Other Liabilities

     146,964         147,859   

Total Equity

     1,048,460         993,030   
                 

Total Liabilities and Equity

   $ 2,750,196       $ 2,706,697   
                 


CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

 

     Three Months Ended  
     March 31,  
     2011     2010  

Operating Activities:

    

Net income attributable to common shareholders

   $ 48,467      $ 33,234   

Noncontrolling interest in subsidiaries’ losses

     (89     (50
                

Net income before allocations to noncontrolling interests

     48,378        33,184   

Gain on divestiture

     (4,258     —     

Depreciation and amortization

     15,774        14,437   

Stock-based compensation expense

     3,503        3,172   

Defined benefit plans and postretirement expense

     2,749        2,375   

Deferred income taxes

     6,893        6,682   

Cash used for operating working capital

     (67,250     (31,687

Defined benefit plans and postretirement contributions

     (4,779     (1,076

Environmental payments, net of reimbursements

     (4,593     (3,200

Other

     142        4,056   
                

Subtotal

     (3,441     27,943   

Asbestos related payments, net of insurance recoveries

     (12,725     (11,125
                

Total (used for) provided from operating activities

     (16,166     16,818   
                

Investing Activities:

    

Capital expenditures

     (8,138     (4,119

Proceeds from disposition of capital assets

     4,553        —     

Payment for acquisition, net of cash acquired

     —          (51,167

Proceeds from divestiture

     1,000        —     
                

Total used for investing activities

     (2,585     (55,286
                

Financing Activities:

    

Dividends paid

     (13,474     (11,743

Reacquisition of shares on open market

     (29,999     —     

Stock options exercised - net of shares reacquired

     12,552        4,714   

Excess tax benefit from stock-based compensation

     3,952        391   

Change in short-term debt

     (76     (3,046
                

Total used for financing activities

     (27,045     (9,684
                

Effect of exchange rate on cash and cash equivalents

     6,017        (4,978
                

Decrease in cash and cash equivalents

     (39,779     (53,130

Cash and cash equivalents at beginning of period

     272,941        372,714   
                

Cash and cash equivalents at end of period

   $ 233,162      $ 319,584   
                


CRANE CO.

Order Backlog

(in thousands)

 

     March 31,
2011
    December 31,
2010
    September 30,
2010
     June 30,
2010
     March 31,
2010
 

Aerospace & Electronics

   $ 454,559      $ 431,467      $ 401,585       $ 394,554       $ 388,169   

Engineered Materials

     13,826        11,831        11,367         12,496         14,810   

Merchandising Systems

     25,008     30,170     18,044         20,346         21,947   

Fluid Handling

     305,255        271,825        266,578         257,840         253,946   

Controls

     24,015        22,354        27,575         28,711         26,910   
                                          

Total Backlog

   $ 822,663      $ 767,647      $ 725,149       $ 713,947       $ 705,782   
                                          

 

* Includes Order Backlog of $5.3 million in March 31, 2011 and $8.4 million in December 2010 pertaining to the 2010 acquisition of Money Controls.


CRANE CO.

Non-GAAP Financial Measures

(in thousands)

 

     Three Months Ended  
     March 31,  
     2011     2010  
CASH FLOW ITEMS     

Cash (Used for) Provided from Operating Activities before Asbestos - Related Payments

   $ (3,441   $ 27,943   

Asbestos Related Payments, Net of Insurance Recoveries

     (12,725     (11,125
                

Cash (Used for) Provided from Operating Activities

     (16,166     16,818   

Less: Capital Expenditures

     (8,138     (4,119
                

Free Cash Flow

   $ (24,304   $ 12,699   
                

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, management believes that non-GAAP financial measures which exclude certain non-recurring items present additional useful comparisons between current results and results in prior operating periods, providing investors with a clearer view of the underlying trends of the business. Management also uses these non-GAAP financial measures in making financial, operating, planning and compensation decisions and in evaluating the Company’s performance.

In addition, Free Cash Flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate liquidity from its operating activities. The measure of Free Cash Flow does not take into consideration certain other non-discretionary cash requirements such as, for example, mandatory principle payments on the Company’s long-term debt. Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.

Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in the context of the definitions of the elements of such measures we provide and in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.